ISPH Stock Overview
Ibnsina Pharma operates as a pharmaceutical distributor in Egypt.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
Ibnsina Pharma Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ج.م2.58 |
52 Week High | ج.م4.15 |
52 Week Low | ج.م1.60 |
Beta | 0.29 |
1 Month Change | -4.44% |
3 Month Change | -20.86% |
1 Year Change | 58.38% |
3 Year Change | -21.20% |
5 Year Change | -67.65% |
Change since IPO | -40.53% |
Recent News & Updates
Recent updates
Shareholder Returns
ISPH | EG Healthcare | EG Market | |
---|---|---|---|
7D | -3.0% | -4.3% | -7.5% |
1Y | 58.4% | 30.7% | 45.4% |
Return vs Industry: ISPH exceeded the EG Healthcare industry which returned 30.7% over the past year.
Return vs Market: ISPH exceeded the EG Market which returned 45.4% over the past year.
Price Volatility
ISPH volatility | |
---|---|
ISPH Average Weekly Movement | 10.4% |
Healthcare Industry Average Movement | 6.5% |
Market Average Movement | 8.8% |
10% most volatile stocks in EG Market | 13.3% |
10% least volatile stocks in EG Market | 4.7% |
Stable Share Price: ISPH's share price has been volatile over the past 3 months.
Volatility Over Time: ISPH's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Mohamed Mohsen Mahgoub | www.ibnsina-pharma.com |
Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and hospitals and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services.
Ibnsina Pharma Fundamentals Summary
ISPH fundamental statistics | |
---|---|
Market cap | ج.م2.60b |
Earnings (TTM) | ج.م173.14m |
Revenue (TTM) | ج.م33.95b |
15.0x
P/E Ratio0.1x
P/S RatioIs ISPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ISPH income statement (TTM) | |
---|---|
Revenue | ج.م33.95b |
Cost of Revenue | ج.م31.43b |
Gross Profit | ج.م2.52b |
Other Expenses | ج.م2.34b |
Earnings | ج.م173.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.17 |
Gross Margin | 7.41% |
Net Profit Margin | 0.51% |
Debt/Equity Ratio | 855.3% |
How did ISPH perform over the long term?
See historical performance and comparison